The heads of nine biopharmaceutical companies pledge to fully vet their COVID-19 candidate vaccines before asking for federal approval to market them.
With Trump promising a COVID-19 vaccine ‘very soon,’ industry developers pledge to keep politics out of science
More Stories
Brazil rolls out COVID-19 vaccination plan
First Pfizer COVID-19 vaccine shipments to be delivered to US distribution sites starting Monday
CDC advisory panel recommends Covid-19 vaccine for people 16 and over